Measuring bleeding as an outcome in clinical trials of prophylactic platelet transfusions.

Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

Volumn 2012, Issue , 2012, Pages 157-160

  Bercovitz, Rachel S ^a   O'Brien, Sarah H ^b  

^a CHILDREN S HOSPITAL COLORADO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; BLEEDING; BLOOD; CASE REPORT; CHILD; CLINICAL TRIAL (TOPIC); CYTOLOGY; FEMALE; HEMATOLOGY; HUMAN; METHODOLOGY; ONCOLOGY; QUALITY OF LIFE; REVIEW; RISK; SEVERITY OF ILLNESS INDEX; STANDARD; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION;

BLOOD PLATELETS; CHILD; CLINICAL TRIALS AS TOPIC; FEMALE; HEMATOLOGY; HEMORRHAGE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MEDICAL ONCOLOGY; PLATELET COUNT; PLATELET TRANSFUSION; QUALITY OF LIFE; RISK; SEVERITY OF ILLNESS INDEX;

MLCS; MLOWN;

EID: 84879324756     PISSN: None     EISSN: 15204383     Source Type: Journal    
DOI: 10.1182/asheducation.v2012.1.157.3806851     Document Type: Review

References (0)